InvestorsHub Logo
Followers 83
Posts 43609
Boards Moderated 1
Alias Born 01/05/2010

Re: myarmalite post# 26323

Wednesday, 12/26/2012 12:47:27 AM

Wednesday, December 26, 2012 12:47:27 AM

Post# of 130516

Now you should post the FDA orphan status guide so everyone can see how much easier it is.

Here is something to think about... You sure MANF is even classified as a drug.....




Reponding to your post reminded me of this scene:

http://www.google.com/search?sourceid=navclient&ie=UTF-8&q=woody+allen+and+marshall+mccluhan


In this case I'll let the FDA and Amarantus serve as M. McCluhan for your statement and question.

http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/default.htm

"The approval of an orphan designation request [i]does not alter the standard regulatory requirements and process for obtaining marketing approval. Safety and efficacy of a compound must be established through adequate and well-controlled studies."


http://www.amarantus.com/about-us.html

"The Company is currently focusing on the development of its lead drug candidate AMRS001 for Parkinson’s Disease and Cardiac Ischemia." (read more – AMRS001)